A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age
Keywords: RSV vaccine; Palivizumab-competitive antibody; anti-F immunoglobulin G (IgG); Neutralizing antibody; Maternal immunization, transplacental antibody transfer;